Order Article Reprints

Lin I-C, Chang C-H, Chong YB, Kuo S-H, Cheng Y-W, Lieu A-S, Tseng T-T, Lin C-J, Tsai H-P, Kwan A-L. Role of Nucleobindin-2 in the Clinical Pathogenesis and Treatment Resistance of Glioblastoma. Cells. 2023; 12(19):2420. https://doi.org/10.3390/cells12192420

Lin, I-Cheng, Chih-Hui Chang, Yoon Bin Chong, Shih-Hsun Kuo, Yu-Wen Cheng, Ann-Shung Lieu, Tzu-Ting Tseng, Chien-Ju Lin, Hung-Pei Tsai, and Aij-Lie Kwan. 2023. "Role of Nucleobindin-2 in the Clinical Pathogenesis and Treatment Resistance of Glioblastoma" Cells 12, no. 19: 2420. https://doi.org/10.3390/cells12192420

Lin, I.-C., Chang, C.-H., Chong, Y. B., Kuo, S.-H., Cheng, Y.-W., Lieu, A.-S., Tseng, T.-T., Lin, C.-J., Tsai, H.-P., & Kwan, A.-L. (2023). Role of Nucleobindin-2 in the Clinical Pathogenesis and Treatment Resistance of Glioblastoma. Cells, 12(19), 2420. https://doi.org/10.3390/cells12192420